Fenofibrate is a fibrate. It activates PPAR-alpha, a nuclear receptor that increases the breakdown of triglyceride-rich particles and raises HDL. That makes it a different proposition from a statin: statins primarily lower LDL cholesterol, while fenofibrate primarily lowers triglycerides. The reason for taking it is often not what people assume, and it is rarely about preventing heart attacks.
Follow the instructions on your label. This guide contains no doses.
The main reason it is prescribed
Very high triglycerides cause acute pancreatitis, which is painful, dangerous and sometimes fatal.
Above a certain level the risk becomes substantial, and lowering triglycerides to prevent it is the clearest indication for a fibrate - a different objective from the long-term cardiovascular prevention statins are for.
Seek urgent help for severe abdominal pain radiating to the back, with vomiting.
The cardiovascular evidence is mixed
Large trials of fibrates added to a statin did not show a clear reduction in cardiovascular events across all participants.
Subgroup analyses suggested benefit specifically in people with high triglycerides and low HDL - a pattern common in type 2 diabetes and metabolic syndrome - and that subgroup is where fibrates are still used for cardiovascular reasons.
For most people needing lipid treatment for cardiovascular risk, a statin is the treatment, with ezetimibe added if the target is not reached. See ezetimibe and cholesterol numbers.
Combining with a statin
Both fibrates and statins can cause muscle damage, and the risk rises when they are combined.
Gemfibrozil is the one to avoid. It interferes with statin clearance through a transporter mechanism and the combination has caused serious muscle breakdown - it should not be used with a statin.
Fenofibrate does not share that interaction and is the fibrate of choice when one is needed alongside a statin. The combination still needs care and monitoring.
Seek medical advice promptly for severe unexplained muscle pain or weakness, particularly with dark urine. See statins and muscle pain.
The creatinine rise
Fenofibrate causes a small, reversible rise in creatinine - and therefore an apparent fall in eGFR - without damaging the kidney.
It reflects an effect on creatinine production and handling rather than a loss of function, and it reverses on stopping.
The practical problem is that a GP seeing that result out of context may conclude kidney function has deteriorated. If anyone raises your kidney results, mention fenofibrate.
Genuine kidney function is still monitored, and the dose is reduced in impairment - see medicines that affect your kidneys.
Gallstones
Fibrates increase cholesterol saturation in bile and raise the risk of gallstones.
Report pain in the upper right abdomen, particularly after fatty meals, or jaundice.
The risk rises further when combined with ezetimibe.
Other side effects
Nausea, abdominal discomfort and diarrhoea are the common ones, usually settling.
Raised liver enzymes occur and liver function is monitored - report jaundice, dark urine or persistent nausea. See medicines and your liver.
Headache, rash and photosensitivity are reported - see medicines that make you sun-sensitive.
A rise in homocysteine occurs, of uncertain significance.
Warfarin
Fenofibrate increases warfarin's effect, and the INR needs checking after starting, after any dose change, and after stopping.
See warfarin.
What raises triglycerides in the first place
This matters more than with LDL, because triglycerides respond considerably to things other than medicine.
- Alcohol - often the single largest contributor, and reducing it can transform the result
- Refined carbohydrate and sugary drinks, more than dietary fat
- Poorly controlled diabetes - see metformin
- Untreated hypothyroidism - see levothyroxine
- Excess weight
- Medicines including some steroids, some antipsychotics, oestrogen and some HIV treatments
Addressing those can reduce triglycerides substantially, sometimes enough to avoid a fibrate. Thyroid function and glucose are usually checked before treating raised lipids, because treating the cause works better than treating the number.
Omega-3
High-dose omega-3 preparations also lower triglycerides and are used for the same purpose, sometimes alongside.
Over-the-counter fish oil supplements contain far lower doses and do not achieve the same effect - the prescribed preparations are a different proposition from a supermarket capsule.
Bezafibrate and the alternatives
Bezafibrate is the other fibrate in common UK use and behaves similarly. Gemfibrozil is largely avoided now because of the statin interaction described above.
Where triglycerides are very high, treatment often combines a fibrate with dietary change and, sometimes, high-dose omega-3. Where they are only modestly raised and cardiovascular risk is the concern, a statin remains the priority - lowering LDL does more for that than lowering triglycerides.
Taking it
Once daily. Some formulations should be taken with food to improve absorption, others are unaffected - check your product, since the preparations differ meaningfully and are not interchangeable.
Fasting lipid samples used to be required; most laboratories now accept non-fasting samples, but follow whatever instruction you are given.
More on how the main families of medicine work in the Medicines section, including Simvastatin: Grapefruit, Timing and Dose Caps.